Production (Stage)
eXoZymes, Inc.
EXOZ
$12.81
-$0.34-2.59%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -100.99% | -- | -- |
| Total Other Revenue | -- | -- | 145.10% | -- | -- |
| Total Revenue | -- | -- | -100.70% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -100.70% | -- | -- |
| SG&A Expenses | 161.43% | 203.50% | 197.85% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 167.04% | 217.87% | 298.18% | -- | -- |
| Operating Income | -168.17% | -230.28% | -332.98% | -- | -- |
| Income Before Tax | -142.78% | -193.63% | -300.54% | -- | -- |
| Income Tax Expenses | -100.00% | -100.00% | -30.19% | -- | -- |
| Earnings from Continuing Operations | -139.12% | -187.53% | -284.74% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -139.12% | -187.53% | -284.74% | -- | -- |
| EBIT | -168.17% | -230.28% | -332.98% | -- | -- |
| EBITDA | -181.07% | -254.20% | -387.80% | -- | -- |
| EPS Basic | -111.40% | -172.44% | -284.29% | -- | -- |
| Normalized Basic EPS | -114.73% | -178.26% | -300.16% | -- | -- |
| EPS Diluted | -111.40% | -172.44% | -284.29% | -- | -- |
| Normalized Diluted EPS | -114.73% | -178.26% | -300.16% | -- | -- |
| Average Basic Shares Outstanding | 13.48% | 5.01% | 0.09% | -- | -- |
| Average Diluted Shares Outstanding | 13.48% | 5.01% | 0.09% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |